Frank Gu

Frank Gu has been working in the field of nanotechnology engineering since 2008. Frank started off as an Assistant Professor at the University of Waterloo, where they also held the position of Canada Research Chair in Nanotechnology Engineering. In 2015, they became the Chairman and CEO of H2nanO. In 2018, they joined the University of Toronto as Professor of Chemical Engineering & Applied Chemistry and NSERC Senior Industrial Chair in Nanotechnology Engineering. Frank also founded MyX Therapeutics in 2018, where they currently serve as CSO/Founder.

Frank Gu completed a Postdoc at the Massachusetts Institute of Technology in Chemical Engineering, followed by a Doctor of Philosophy (Ph.D.) in Chemical Engineering at Queen's University.